Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
100.98
+0.03 (0.03%)
At close: Aug 13, 2025, 4:00 PM
101.10
+0.12 (0.12%)
Pre-market: Aug 14, 2025, 8:25 AM EDT
Allakos Stock Forecast
Stock Price Forecast
The 3 analysts that cover Allakos stock have a consensus rating of "Hold" and an average price target of $100.67, which forecasts a -0.31% decrease in the stock price over the next year. The lowest target is $100 and the highest is $101.
Price Target: $100.67 (-0.31%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
The average analyst rating for Allakos stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 5 | 5 | 5 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | -0.97% | Apr 16, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.02% | Mar 4, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.02% | Feb 12, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +0.02% | Jul 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.02% | Jul 25, 2024 |
Financial Forecast
Revenue This Year
2.50B
from 2.35B
Increased by 6.29%
Revenue Next Year
2.63B
from 2.50B
Increased by 5.29%
EPS This Year
4.88
from 1.31
Increased by 272.34%
EPS Next Year
5.27
from 4.88
Increased by 8.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.6B | 2.8B | 2.9B |
| Avg | 2.5B | 2.6B | 2.8B |
| Low | 2.4B | 2.5B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.4% | 11.0% | 9.0% |
| Avg | 6.3% | 5.3% | 5.4% |
| Low | 1.2% | -1.0% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.53 | 5.96 | 5.49 |
| Avg | 4.88 | 5.27 | 5.20 |
| Low | 4.49 | 4.56 | 4.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 322.4% | 22.3% | 4.2% |
| Avg | 272.3% | 8.1% | -1.3% |
| Low | 242.6% | -6.6% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.